Twilio commits $10 million to COVAX for equitable vaccine distribution

Twilio is committing $10 million to COVAX, a global public-private partnership aimed at developing and distributing COVID-19 vaccines for underserved countries. This funding supports COVAX's goal of procuring 2 billion vaccines, with the ultimate aim of achieving equitable vaccine access worldwide. As part of Twilio's multi-year initiative to help end the pandemic, this donation is part of a broader commitment to provide technology, grant funding, and volunteer support to organizations building communications for vaccine administration. By supporting COVAX, Twilio aims to increase global vaccine supply and enable NGOs, healthcare organizations, and governments to vaccinate their populations effectively.